Financial Counselors Inc Eli Lilly & CO Transaction History

Financial Counselors Inc

$6.67 Billion
Q3 2024

A detailed history of Financial Counselors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Counselors Inc holds 48,793 shares of LLY stock, worth $37.5 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

48,793

Previous 51,548 5.34%

Holding current value

$37.5 Million

Previous $46.7 Million 7.38%

% of portfolio

0.65%

Previous 0.76%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $2.13 Million - $2.64 Million	-2,755 Reduced 5.34%	48,793 $43.2 Million
Q2 2024 Aug 01, 2024	SELL	$724.87 - $909.04 $1.09 Million - $1.36 Million	-1,498 Reduced 2.82%	51,548 $46.7 Million
Q1 2024 May 02, 2024	BUY	$592.2 - $792.28 $665,632 - $890,522	1,124 Added 2.16%	53,046 $41.3 Million
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $2.1 Million - $2.48 Million	4,003 Added 8.35%	51,922 $30.3 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $2.17 Million - $3 Million	-5,003 Reduced 9.45%	47,919 $25.7 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $453,857 - $606,860	-1,294 Reduced 2.39%	52,922 $24.8 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $171,467 - $201,380	-552 Reduced 1.01%	54,216 $18.6 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $491,006 - $572,121	-1,527 Reduced 2.71%	54,768 $20 Million
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $24,014 - $27,367	81 Added 0.14%	56,295 $18.2 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $520,946 - $611,667	1,869 Added 3.44%	56,214 $18.2 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $60,315 - $74,956	257 Added 0.48%	54,345 $15.6 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $194,270 - $241,090	-864 Reduced 1.57%	54,088 $14.9 Million
Q3 2021 Oct 26, 2021	BUY	$221.6 - $272.71 $62,491 - $76,904	282 Added 0.52%	54,952 $12.7 Million
Q2 2021 Aug 03, 2021	SELL	$180.55 - $233.54 $125,301 - $162,076	-694 Reduced 1.25%	54,670 $12.5 Million
Q1 2021 Apr 29, 2021	BUY	$164.32 - $212.72 $394,532 - $510,740	2,401 Added 4.53%	55,364 $10.3 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $4,044 - $5,351	31 Added 0.06%	52,963 $8.94 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $122,093 - $141,223	-835 Reduced 1.55%	52,932 $7.84 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $1.75 Million - $2.1 Million	-12,808 Reduced 19.24%	53,767 $8.83 Million
Q1 2020 Apr 23, 2020	SELL	$119.05 - $147.35 $48,096 - $59,529	-404 Reduced 0.6%	66,575 $9.24 Million
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $139,102 - $172,291	1,301 Added 1.98%	66,979 $8.8 Million
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $1,495 - $1,626	-14 Reduced 0.02%	65,678 $7.35 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $27,365 - $31,942	247 Added 0.38%	65,692 $7.28 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $2.54 Million - $2.99 Million	-22,852 Reduced 25.88%	65,445 $8.49 Million
Q4 2018 Feb 01, 2019	SELL	$105.9 - $118.64 $153,343 - $171,790	-1,448 Reduced 1.61%	88,297 $10.2 Million
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $183,311 - $229,106	-2,135 Reduced 2.32%	89,745 $9.63 Million
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $113,322 - $130,059	-1,497 Reduced 1.6%	91,880 $7.84 Million
Q1 2018 Apr 26, 2018	BUY	$74.21 - $87.6 $172,983 - $204,195	2,331 Added 2.56%	93,377 $7.23 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $56,046 - $60,116	-684 Reduced 0.75%	91,046 $7.69 Million
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $59,960 - $66,550	-778 Reduced 0.84%	91,730 $7.85 Million
Q2 2017 Aug 10, 2017	BUY	N/A	92,508	92,508 $7.61 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Eli Lilly & CO Transaction History